Navigation Links
Study: Genetic risk for substance use can be neutralized by good parenting

Athens, Ga. A genetic risk factor that increases the likelihood that youth will engage in substance use can be neutralized by high levels of involved and supportive parenting, according to a new University of Georgia study.

The study, published in the February issue of the Journal of Consulting and Clinical Psychology, is the first to examine a group of youth over time to see how a genetic risk factor interacts with a child's environment to influence behavior.

"We found that involved and supportive parenting can completely override the effects of a genetic risk for substance abuse," says study co-author Gene Brody, Regents Professor in the UGA College of Family and Consumer Sciences. "It's a very encouraging finding that shows the power of parenting."

Brody and his colleagues, who include UGA Institute for Behavioral Research director Steven Beach and University of Iowa Associate Professor of Psychiatry Robert Philibert, focused their attention on a gene known as 5HTT that's involved in the transport of the brain chemical serotonin. Most people carry two copies of the long version of the gene, but those with one or two copies of the short version have been shown in several studies to have a greater likelihood of consuming alcohol and other substances and to have higher levels of impulsivity and risk taking.

The researchers interviewed 253 African-American families in rural Georgia over a four-year period. After obtaining informed consent from the parents and youth, they collected saliva samples for genetic testing.

The researchers found that nearly 60 percent of the youth had two copies of the long gene, while the remainder had one or two copies of the short gene that confers risk. As expected, the use of substances was low among 11 year-olds and increased as the youth aged. By age 14, 21 percent of the youth had smoked cigarettes, 42 percent had used alcohol, five percent had drank heavily and five percent had used marijuana.

Among youth with the genetic risk factor, those who received low levels of involved and supportive parenting increased their substance use at rate three times higher than youth with high levels of parental support. Among youth with high levels of involved and supportive parenting, the difference in substance abuse was negligible regardless of genetic risk.

"In families that were characterized by strong relationships between children and their parents, the effect of the genetic risk was essentially zero," said Beach, who is also a Distinguished Research Professor in the psychology department of the UGA Franklin College of Arts and Sciences. "With this study and previous studies looking at environmental risk factors such as poverty, we're finding that in many cases the best way to help children is to help families become more resilient."

Involved and supportive parenting is a very powerful tool, and Brody said it's relatively simple to implement. Some examples include parents regularly spending time with children, communicating with them to gauge how they're doing, providing emotional support and helping them with their material and day-to-day needs such as homework.

"We all carry around genetic risks," said Brody, who also directs the UGA Center for Family Research, a unit of the IBR, "but fortunately very few people are impacted by those risks because their environment protects them."


Contact: Sam Fahmy
University of Georgia

Related medicine news :

1. Pediatrics study: Involve adolescents in end-of-life medical decisions
2. U-M Study: 19% of Breast Cancer Patients Dont Receive Recommended Radiation After Mastectomy
3. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
4. Twin study: Diabetes significantly increases risk for Alzheimers disease and other dementia
5. Study: Adding Vimpat significantly reduces partial-onset seizures in adults with epilepsy
6. New study: Short coverage lapses limit childrens access to health care services
7. New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls
8. UNC study: Access to state childrens health insurance programs vital to disabled children
9. UNC study: Postmenopausal womens loss of sexual desire affects health, quality of life
10. Penn study: Breast cancer survivors call for more survivorship care from primary care physicians
11. Study: Growth in research comes at a steep price
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: